Isolated pulmonary capillaritis

Isolated pulmonary capillaritis is an extremely rare condition characterized by inflammation and destruction of the small blood vessels (capillaries) within the lungs, occurring without an identifiable underlying systemic disease. In this condition, neutrophilic infiltration of the alveolar capillary walls leads to damage and disruption of the pulmonary microvasculature, resulting in leakage of blood into the alveolar spaces — a process known as diffuse alveolar hemorrhage (DAH). The disease primarily affects the respiratory system, and patients typically present with hemoptysis (coughing up blood), dyspnea (shortness of breath), anemia (often iron-deficiency anemia from chronic blood loss), and diffuse pulmonary infiltrates on chest imaging. Some patients may experience acute, life-threatening episodes of massive pulmonary hemorrhage, while others have a more indolent course with recurrent episodes. The term 'isolated' distinguishes this entity from pulmonary capillaritis that occurs secondary to systemic vasculitides (such as granulomatosis with polyangiitis, microscopic polyangiitis, or systemic lupus erythematosus) or other autoimmune conditions. By definition, patients with isolated pulmonary capillaritis lack serological markers of systemic autoimmune disease, including ANCA (anti-neutrophil cytoplasmic antibodies) and anti-glomerular basement membrane antibodies, and have no evidence of renal or other organ involvement. Diagnosis is typically confirmed by surgical lung biopsy demonstrating neutrophilic capillaritis with fibrinoid necrosis of alveolar capillary walls and associated alveolar hemorrhage. Treatment is largely based on expert opinion and case reports, as no randomized controlled trials exist for this rare condition. Immunosuppressive therapy is the mainstay of treatment, typically involving systemic corticosteroids as first-line therapy. In refractory or relapsing cases, additional immunosuppressive agents such as cyclophosphamide, azathioprine, or mycophenolate mofetil may be employed. The prognosis is variable; some patients respond well to immunosuppression, while others experience recurrent hemorrhagic episodes requiring long-term therapy. Close monitoring is essential, as some patients initially classified as having isolated pulmonary capillaritis may eventually develop features of a systemic vasculitis over time.

Common questions about Isolated pulmonary capillaritis